(2-chlorophenyl)-(4-fluorophenyl)methanone

We are (2-chlorophenyl)-(4-fluorophenyl)methanone CAS:1806-23-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(2-chlorophenyl)-(4-fluorophenyl)methanone
CAS.NO:1806-23-1
Synonyms:(2-chlorophenyl)-(4-fluorophenyl)methanone
o-chlorophenyl p-fluorophenyl ketone
4-Fluor-2'-chlor-benzophenon
2-Chloro-4'-fluorobenzophenone
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 337.3±22.0 °C at 760 mmHg
Melting Point 60-62°C
Molecular Formula C13H8ClFO
Molecular Weight 234.653
Flash Point 157.8±22.3 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.578
 
Specification:
Appearance:White crystal
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Nuarimol(CAS:63284-71-9).

(2-chlorophenyl)-(4-fluorophenyl)methanone


Related News: Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.38186-84-4 Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.4-Bromo-3-nitrobenzotrifluoride The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.Trietoxisilano CAS:998-30-1 The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.

Related Products
Product Name
(3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione View Details
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole View Details
4-(4-Chlorophenyl)piperidin-4-ol View Details
7-Chloro-5-phenyl-1H-benzo[e]-[1,4]diazepine-2(3H)-thione manufacturer Glycine ethyl ester hydrochloride manufacturer Chlorodimethylsilane manufacturer 1-chloro-4-methoxybutane manufacturer 2-[2-[2-(2-ethylhexanoyloxy)ethoxy]ethoxy]ethyl 2-ethylhexanoate manufacturer